BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31578560)

  • 21. Counterimmunoelectrophoresis employing coccidioidin in serologic testing for coccidioidomycosis.
    Graham AR; Ryan KJ
    Am J Clin Pathol; 1980 Apr; 73(4):574-7. PubMed ID: 6768284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical conference in pulmonary disease. Coccidioidomycosis. Clinical conference in pulmonary disease from the Tucson V.A. Medical Center and the University of Arizona.
    Campbell SC; Winter JA; Bjelland JC; Wieden M; Sobonya RE; Galgiani JN
    Chest; 1982 Apr; 81(4):488-92. PubMed ID: 7067515
    [No Abstract]   [Full Text] [Related]  

  • 23. A review of innate and adaptive immunity to coccidioidomycosis.
    Hung CY; Hsu AP; Holland SM; Fierer J
    Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spherulin and coccidioidin: cross-reactions in dermal sensitivity to histoplasmin and paracoccidioidin.
    Levine HB; Restrepon A; Eyck DR; Stevens DA
    Am J Epidemiol; 1975 Jun; 101(6):512-6. PubMed ID: 1155429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen.
    Cox RA; Brummer E; Lecara G
    Infect Immun; 1977 Mar; 15(3):751-5. PubMed ID: 870430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary coccidioidomycosis with peritoneal involvement mimicking lung cancer with peritoneal carcinomatosis.
    Chung CR; Lee YC; Rhee YK; Chung MJ; Hong YK; Kweon EY; Park SJ
    Am J Respir Crit Care Med; 2011 Jan; 183(1):135-6. PubMed ID: 21193791
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment considerations in pulmonary coccidioidomycosis.
    Hartmann CA; Aye WT; Blair JE
    Expert Rev Respir Med; 2016 Oct; 10(10):1079-91. PubMed ID: 27635942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coccidioidomycosis in hematopoietic stem cell transplant recipients.
    Glenn TJ; Blair JE; Adams RH
    Med Mycol; 2005 Dec; 43(8):705-10. PubMed ID: 16422300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated coccidioidomycosis masquerading as recurrent lymphoma.
    Manning MA; Kuo PH; Yeager AM
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29804084
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic pulmonary coccidioidomycosis.
    Sarosi GA; Parker JD; Doto IL; Tosh FE
    N Engl J Med; 1970 Aug; 283(7):325-9. PubMed ID: 5428479
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis.
    Ampel NM; Giblin A; Mourani JP; Galgiani JN
    Clin Infect Dis; 2009 Jan; 48(2):172-8. PubMed ID: 19072555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis.
    Wack EE; Ampel NM; Sunenshine RH; Galgiani JN
    Clin Infect Dis; 2015 Sep; 61(5):787-91. PubMed ID: 25979308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An imported case of acute pulmonary coccidioidomycosis in an Italian traveller.
    Corpolongo A; Giancola ML; Ghirga P; Oliva A; Mencarini P; Pane S; Bellagamba R; Tommasi C; Antinori A; Nicastri E
    Infection; 2014 Oct; 42(5):921-4. PubMed ID: 24771415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
    Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
    Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.
    Ampel NM; Hector RF; Lindan CP; Rutherford GW
    Mycopathologia; 2006 Feb; 161(2):67-72. PubMed ID: 16463089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coccidioidomycosis in non-endemic areas: a case series.
    Desai SA; Minai OA; Gordon SM; O'Neil B; Wiedemann HP; Arroliga AC
    Respir Med; 2001 Apr; 95(4):305-9. PubMed ID: 11316114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region.
    Zangeneh TT; Lainhart WD; Wiederhold NP; Al-Obaidi MM
    Med Mycol; 2023 Oct; 61(10):. PubMed ID: 37804176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro assays of cellular immunity in progressive coccidioidomycosis: evaluation of suppression with parasitic-phase antigen.
    Harvey RP; Stevens DA
    Am Rev Respir Dis; 1981 Jun; 123(6):665-9. PubMed ID: 7271066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical comparison of two Mexican coccidioidins.
    Castañón-Olivares LR; Laniado-Laborín R; Concepcion T; Muñoz-Hernández B; Aroch-Calderón A; Aranda-Uribe IS; Flores-Sánchez MA; del Rocío González-Martínez M; Hernández-Navarez A; Manjarrez-Zavala ME; Miranda-Mauricio S; Palma G; Pérez-Mejía A
    Mycopathologia; 2010 Jun; 169(6):427-30. PubMed ID: 20177972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coccidioidomycosis: a review and update.
    DiCaudo DJ
    J Am Acad Dermatol; 2006 Dec; 55(6):929-42; quiz 943-5. PubMed ID: 17110216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.